Abstract Microparticles are membrane-derived vesicles that are released from cells during activation or cell death. These particles can serve as mediators of intercellular crosstalk and induce a variety of cellular responses. Previous studies have shown that macrophages undergo apoptosis after phagocytosing microparticles. Here, we have addressed the hypothesis that microparticles trigger this process via lipid pathways. In these experiments, microparticles induced apoptosis in primary macrophage cells or cell lines (RAW 264.7 or U937) with up to a 5-fold increase. Preincubation of macrophages with phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)BP) reduced the microparticle-induced apoptosis in a dose-dependent manner. PtdIns(3,5)BP is a specific inhibitor of the acid sphingomyelinase and thus can block the generation of pro-apoptotic ceramides. Similarly, the preincubation of macrophages with PtdIns(3,5)BP prevented microparticle-induced upregulation of caspase 8, which is a major target molecule of ceramide action in the apoptosis pathway. PtdIns(3,5)BP, however, had no effect on the spontaneous rate of apoptosis. To evaluate further signaling pathways induced by microparticles, the extracellular signal regulated kinase (ERK-) 1 was investigated. This kinase plays a role in activating phospholipases A2 which cleaves membrane phospholipids into arachidonic acid; microparticles have been suggested to be a preferred substrate for phospholipases A2. As shown in our experiments, microparticles strongly increased the amount of phosphorylated ERK1/2 in RAW 264.7 macrophages in a time-dependent manner, peaking 15 min after co-incubation. Addition of PD98059, a specific inhibitor of ERK1, prevented the increase in apoptosis of RAW 264.7 macrophages. Together, these data suggest that microparticles perturb lipid homeostasis of macrophages and thereby induce apoptosis. These results emphasize the importance of biolipids in the cellular cross-talk of immune cells. Based on the fact that in clinical situations with excessive cell death such as malignancies, autoimmune diseases and following chemotherapies high levels of circulating microparticles might modulate phagocytosing cells, a suppression of the immune response might occur due to loss of macrophages.
Introduction
Microparticles are subcellular vesicles that are released from cells by shedding of membraneous blebs. The release of these structures is strongly increased when cells are exposed to proinflammatory or pro-apoptotic stimuli [1] [2] [3] . Consistent with a role of microparticles in the pathogenesis of inflammatory diseases, levels of these structures are elevated in autoimmune diseases such as rheumatoid arthritis [4] , vasculitis [5] , lupus anticoagulant syndrome [6] , and multiple sclerosis [7] . These findings implicate microparticles as novel mediators of inflammation and suggest that the release of microparticles and their biological activities can be targeted in new approaches to immune modulation [8] .
As shown by in vitro studies, microparticles can function as subcellular vectors to deliver proteins and lipids into target cells. This transfer can alter the phenotypic properties of the target cell as well as induce a variety of functional changes [9] . Recently, we have shown that microparticles derived from human Jurkat T-lymphoma cells are rapidly engulfed by RAW 264.7 mouse macrophages, which, in turn, undergo apoptosis [10] . The death of the macrophages leads to further generation of microparticles, albeit with different surface markers. While suggesting a mechanism for loss and functional disturbance of macrophages during inflammation, the mechanisms of apoptosis induced by the microparticles were not defined by these experiments.
In this current study, we have therefore explored this death pathway, focusing on the role of membrane phospholipids in the effects of microparticles on macrophage viability. In the induction of apoptosis, lipid metabolism has been implicated as a central event, with the pathway involving arachidonic acid and sphingomyelin receiving the most attention [11] [12] [13] [14] [15] . Arachidonic acid, which belongs to the group of essential twenty-carbon fatty acids (eicosanoids), is the most abundant polyunsaturated fatty acid among the phospholipid components of cell membranes. Arachidonic acid undergoes cleavage from membrane phospholipids by isoforms of phospholipase A2, which cleave the sn-2-acyl position of 1-ether-linked membrane glycerophospholipids to liberate fatty acids and lysophospholipids [16, 17] .
The activity of phospholipase A2 requires a rearrangement of membrane lipids to expose phosphatidylserine on the external layer [18] .
Shed from stimulated or dying cells, microparticles lose membrane asymmetry with subsequent surface exposure of aminophospholipids [19, 20] . These findings suggest that these structures could provide a substrate for phospholipases that is preferentially cleaved [21] . In this scenario, the accumulation of free arachidonic acid could enhance the activity of acid sphingomyelinase [22] [23] [24] [25] to catalyze the conversion of sphingomyelin to cellular (C2/C16)-ceramides. With an increased concentration of ceramide, apoptosis would then be induced by the activation of caspase 8 and the release of downstream pro-apoptotic factors [26] [27] [28] . Of note, other phospholipases can degrade phospholipids more efficiently when sphingomyelinase is present and active [29] [30] [31] .
Since microparticles consist of a packed phospholipid bilayer with altered membrane asymmetry, we have hypothesized that the transfer of a pool of 1-ether-linked phospholipids into target cells occurring during the phagocytosis of microparticles could perturb cellular arachidonic acid levels. With activated phospholipase A2, the changes in fatty acid metabolism could promote apoptosis in cells phagocytosing microparticles. We have therefore investigated the role of lipid mediators in the induction of macrophage apoptosis following interaction with microparticles and explored the effects of a specific inhibitor of syphingomyelinase. Results presented herein indicate the importance of this enzyme in the induction of apoptosis and the role of lipid mediators in cellular cross-talk stimulated by interaction of macrophages with microparticles.
Materials and methods

Reagents
Arachidonic acid as well as the pan-caspase-inhibitor Z-VAD-FMK were from Sigma (Sigma Chemical Co., St. Louis, MO), D-myo-phosphatidylinositol-3,5-bisphosphate [PtdIns(3,5)P] was purchased from Echelon Biosciences Incorporated (Salt Lake City, UT, USA). PD098059 (2 -amino-3 -methoxyflavone) was from Promega (Madison, WI, USA). Phycoerythrin (PE)-labelled Annexin was from BD Biosciences Pharmingen (San Diego, CA, USA). JC-1 (5,5 ,6,6 -tetrachloro-1,1 ,3,3 -tetraethylbenzimidazolylcarbocyanine Iodide) was purchased from Calbiochem (San Diego, CA, USA). Cell Signaling Cytobeads for ERK1/2 and JNK1/2 were from BD Biosciences Pharmingen.
Cells/cell cultures
Mouse macrophage cell line RAW 264.7 (adherent), human U937 (non-adherent), and Jurkat T lymphoma cells were purchased from ATCC (Manassas, VA) and cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco) containing 2 mmol/l L-glutamine. DMEM was supplemented with 10% heat-inactivated fetal calf serum (FCS), 15 mmol/l HEPES, 50 µg/ml streptomycin, 100 U of penicillin, and 2 µl/ml amphotericine B (all from Gibco).
For activation, Jurkat T cells were stimulated with interleukin (IL-)2 (10 ng/ml) and U937 cells were stimulated with concanavalin (1 µg/ml; both from Sigma Chemical Co., St Louis, MO) in DMEM with 10% FCS for 12 h. After stimulation, the supernatants were collected and microparticles were isolated immediately as described previously [32] . For coculture experiments, 10 5 confluent RAW 264.7 macrophages or 3 × 10 5 U937 cells were incubated for 6 and 36 h with freshly isolated microparticles from activated Jurkat T-cells.
The number of cells was determined by the CASY-1 cell counter (Schärfe System, Reutlingen, Germany).
Phagocytosis of microparticles by RAW macrophages was prevented by using anopore membrane systems (pore size 0.2 µm) as cell culture inserts (Nunc GmbH, Wiesbaden, Germany), on which microparticles resuspended in PBS were added.
Isolation of primary macrophages
For the isolation of primary macrophages, buffy coats from healthy donors were obtained from the local blood bank. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll/Hypaque (Pharmacia Biotech) density gradient centrifugation. After incubation with anti-human CD14-microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), primary macrophages were isolated by positive selection magnetic cell sorting (MACS) according to the manufacture's instructions. After adding 50 ng/ml GM-CSF at the initial day of culture, freshly isolated macrophages were cultured in modified Roswell Park Memorial Institute medium (RPMI 1640, with supplements as described above) for 7 days prior to incubation experiments.
Isolation of Jurkat-derived microparticles Microparticles were prepared as described previously [32] . Briefly, cell culture supernatants obtained from Jurkat T-cells stimulated for 12 h were centrifuged at 1500 g for 10 min to remove suspended cells. Supernatants were then centrifuged twice at 100,000 g for 20 min at 14
• C by using a Centrikon T-1065 centrifuge with a TST28.38 head (Kontron Instruments, Munich, Germany). Pelleted microparticles were resuspended in phosphate-buffered saline (PBS, pH 7.5). The microparticles were then either quantified and characterized by flow cytometry analysis or used for coculture experiments with RAW 264.7 or U937 cells. The number of microparticles as counted by FACS was adjusted to the number of RAW 264.7 or U937 cells, respectively.
FACS
Flow cytometry was performed using a FACScan flow cytometer (Becton Dickinson). A minimum of 10,000 cells per sample were acquired in list mode and analyzed using Cell quest software (Becton Dickinson Immunocytometry System, San Jose, CA).
Detection of apoptosis
Apoptosis was assessed by analyzing Annexin V-binding properties of membranes, measurement of the mitochondrial potential, and caspase 8 activity. Briefly, a total of 1 × 10 5 RAW macrophages and 3 × 10 5 human U937 cells were stimulated with 3 × 10 6 Jurkat-derived microparticles as described above. Inhibitor of acid sphingomyelinase was added in concentrations of 5 and 10 µM. Inhibition of general caspase activity was achieved by using 50 µM of the pancaspase-inhibitor Z-VAD-FMK (Sigma). RAW macrophages were pre-incubated with Z-VAD-FMK for 1 h before adding microparticles. After 6 and 36 h, the cells were then examined for apoptosis. In all apoptosis assays, negative controls consisted of untreated macrophages.
Annexin staining 1 × 10 5 cells were examined for apoptosis using Annexin V -PE according to the manufacturer's protocol. Briefly, adherent cells were trypsinized, centrifuged at 500 g for 10 min, and resuspended in 100 µl of FACS binding buffer (BD Pharmingen, San Diego, CA, USA). Annexin V -PE was added directly to the cells. After incubation for 15 min at room temperature, the cells were analyzed by FACS (FACScalibur, Becton Dickinson Mansfield, MA, USA).
Determination of mitochondrial membrane potential ( ϕ)
ϕ was analyzed by a previously described method which allows the measurement of ϕ in intact cells [33, 34] . Briefly, JC-1 is a lipophilic cation that can selectively enter into mitochondria [35] . JC-1 exists in a monomeric form emitting at 527 nm after excitation at 490 nm; however, depending on ϕ, JC-1 is able to form J-aggregates that are associated with a large shift in emission (590 nm) [36, 37] . Thus, the color of the dye changes reversibly from green to greenish orange as the mitochondrial membrane becomes more polarized as a marker of late apoptosis [35] . Both colors can be detected using filters commonly mounted in flow cytometers, so that the green emission can be analysed in fluorescence channel 1 (FL1) and the greenish orange emission in channel 2 (FL2). Cell suspensions were incubated in complete medium with JC-1 (5 µg/ml) for 10 min at room temperature in the dark. At the end of the incubation period, the cells were washed once in cold phosphate-buffered saline (PBS), resuspended in a total volume of 400 µl and analysed by FACS.
Caspase 8 activity
Cells were examined for apoptosis using a fluorimetric caspase 8 activity detection assay (Biovision, Mountain view, CA) according the manufacture's instructions. Briefly, cells were washed with PBS and resuspended in 50 µl of Cell Lysis Buffer. After 10 min incubation period on ice, 50 µl reaction buffer was added to the permeabilized cells. The cells were then stained with anti-active caspase 8 substrate (IETD-AFC), incubated for 2 h at 37
• C, and measured using a microtiter fluorescence reader plate (Witec AG, Biotec, Littau, Switzerland). Data were analyzed by using KC4 software (Bio-Tek Instruments, Vermont, USA).
Inhibition of acid sphingomyelinase
Acid sphingomyelinase (aSMase) catalyzes the lysosomal degradation of sphingomyelin to phosphorylcholine and ceramide. Inhibition of aSMase was performed using L-alpha-phosphatidyl-D-myo-inositol-3,5-bisphosphate (PtdIns3, 5BP), a naturally occurring substance detected in mammalian, plant and yeast cells, which has been recently characterized [25] . Ptins3,5BP was used in concentrations of 2-10 µM, which is within the range of the ID50 of PTins3,5BP as described previously [25] . The effect on cell viability was determined by trypan blue exclusion. Briefly, respective concentrations of PtdIns3,5BP were added to U937 cells. After 6 h and 36 h, 50 µl of cell suspensions were mixed with 50 µl trypan blue and analysed using the Neubauer counting chamber. Compared to untreated U937 cells, there was no increase in the number of blue colored cells.
Analysis of MAP-Kinases activation
Phosphorylation of MAP-K (ERK1/2 and JNK 1/2) was determined by FACS analysis using Cell Signaling Flex Set assay procedure (BD Biosciences Pharmingen, San Diego, CA, USA) according the instructions of the manufacturer.
Inhibition of MAP-Kinases (MEK1/ERK1)
Inhibition of MEK1/ERK1 was performed using PD098059, a selective blocking agent of the activation of MEK1. PD098059 was used in concentrations of 10 µM, which is within the range of the ID50 of PD098059 as shown previously [38] . Trypan blue analysis of cytotoxicity after 6 h showed no effect on cell viability determined by cell counting.
Statistical analysis
All data are expressed as mean ± standard deviation (SD). Statistical analysis was performed using the GraphPad Prism Software, 4.03 (Graph Pad Software Inc., San Diego, CA). For analysis between different groups the Mann-Whitney test was used, and a value of p < 0.05 was considered statistical significant.
Results
Induction of apoptosis in macrophage cells by microparticles
Previous studies have shown that microparticles released from Jurkat T-cells are cleared by RAW 264.7 macrophages and, subsequently, induce apoptosis in these cells in a dosedependent manner [10] . Consistent with these findings, microparticles derived from Jurkat T-cells stimulated with IL-2 induced apoptosis in RAW 264.7 macrophages as determined by Annexin V staining and FACS analysis 36 h after incubation. The frequency of spontaneous apoptotic cells in cultures of RAW 264.7 macrophages was 5.3 ± 1.0%, but this number was significantly increased to 40.2. ± 7.7% upon incubation with 3 × 10 6 Jurkat-derived microparticles. In these experiments, the number of microparticles used was within the physiological range of levels of circulating microparticles reported previously [4, 39] .
To evaluate whether human macrophages also undergo apoptosis after incubation with microparticles, microparticles from Jurkat cells were added to 3 × 10 5 human U937 cells as well as 3 × 10 5 primary macrophages from healthy donors. In both conditions, apoptosis was strongly induced in macrophages 36 h after incubation with microparticles. In human U937 cells, the induction of apoptosis was less prominent (by about 3 fold from 12.0 ± 3.6% to 35.3 ± 6.0%); this difference may relate to the lower phagocytotic capacity of these myeloid precursor cells (Fig. 1) . In contrast, cells without phagocytosing capacity such as dermal and synovial fibroblasts derived from different diseases did not show an increased rate of apoptosis upon treatment with microparticles (data not shown). In a next step, we used cell culture inserts as microfilters to prevent direct contact and phagocytosis of microparticles by RAW macrophages. Anopore filters of 0.2 µm strongly reduced the microparticle-induced apoptosis by 53.3 ± 4.3% after 36 h as measured by FACS analysis using Annexin V-PE. These data suggest that either direct cell contact and most likely, phagocytosis, is required to induce apoptosis in RAW 264.7 macrophages by microparticles. These results were further confirmed by incubating macrophages with microparticle-free supernatant that did not change the rate of apoptosis of target cells.
To explore further mechanisms of macrophage apoptosis in this system, we first analyzed whether microparticles from various origins can induce apoptosis in target cells to an equivalent extent. We therefore stimulated both Jurkat T-cells and human U937 cells to induce the production of microparticles. These particles were isolated after 12 h and then added at a concentration of 3 × 10 6 to 10 5 RAW 264.7 macrophages. Six hours after incubation, apoptosis was measured by FACS analysis using JC-1. With microparticles from both sources, a strong shift of the fluorescent signal from greenish-orange (fluorescence (FL-) 1 and FL-2 double-positive) to green (FL1 single-positive) could be observed. This shift was due to depolarising changes of the mitochondrial membrane potential, indicating apoptotic events in microparticle-stimulated cells compared to untreated control macrophages. increased the apoptotic RAW 264.7 cell population from 5% to 14.5 ± 4.4% (Fig. 2a) , while microparticles from U937 cells increased apoptosis from 5% to 22.0 ± 1.8% (Fig. 2b) .
The effect of inhibiting acid sphingomyelinase on microparticle-induced apoptosis
Following cell stimulation, isoforms of phospholipase A2 can cleave membrane phospholipids to liberate arachidonic acid, which, in turn, activates the enzyme acid sphingomyelinase (aSMase) to metabolize sphingomyelin into ceramides. To investigate whether microparticles activate the apoptotic program in phagocytes through the arachidonic acid pathway, RAW 264.7 macrophages were incubated with different concentrations of arachidonic acid for 36 h before analysis of apoptosis. As shown in Fig. 3 , arachidonic acid dose-dependently induced apoptosis in macrophages, with maximum effects observed at 100 µM.
To assess the down-stream effects of archidonic acid, RAW 264.7 macrophages were next pre-incubated for 2 h with varying concentrations of the specific aSMase-inihibitor phosphatidylinositol-3,5-biphosphate [Ptins(3,5)BP] [25] before adding microparticles. Apoptosis was then tested. Figure 4 shows the effects of Ptins(3,5)BP on macrophages that were incubated for 6 and 36 h with microparticles. In these experiments, Ptins(3,5)BP decreased the apoptosisinducing effect of microparticles on macrophages in a dosedependent manner. Six hours after incubation, Ptins(3,5)BP reduced the fraction of cells with a depolarised mitochondrial potential by 36.5 ± 7.6% (5 µM) and by 66 ± 17.8% (10 µM; p < 0.05) respectively. Similarly, FACS analysis performed after 36 h showed that the depolarisation of the mitochondrial potential as seen in early apoptosis could be prevented by adding Ptins(3,5)BP to RAW 264.7 macrophages that were incubated with Jurkat-and U937-derived microparticles. The higher dose of this inhibition produced statistically significant inhibition in both experimental conditions. In addition, RAW macrophages were preincubated with the general caspase inhibitor Z-VAD-FMK before microparticles were added. Rates of apoptosis were reduced, in particular when analysed after 6 h (Fig. 4) . These data indicate that the activation of the phospholipide-ceramide pathway by microparticles results in both caspase-dependent and -independent cell death with caspases mainly involved during the early stages of apoptosis.
The effect of Ptins(3,5)BP on the basal rate of apoptosis Untreated U937 cells showed a frequency of Annexin Vpositive cells of 12.0 ± 3.6% after 36 h of culture. To exclude the possibility that the observed reduction in the Annexin Vpositive population after co-incubation with microparticles and Ptins(3,5)BP resulted from a reduction of the spontaneous rate of apoptosis, U937 cells were incubated with medium alone or in combination with different concentrations of Ptins(3,5)BP. Staining with Annexin V and FACS analysis after 36 h showed no differences in the intensity of the fluorescent signals between untreated cells and aSMaseinhibited cells at any concentration. In addition, the treatment with Ptins(3,5)BP had no toxic effects on cells at the concentrations used in the study, as measured by trypan blue exclusion (see experimental procedures). The effects of microparticles on caspase 8 activity in macrophage target cells Arachidonic acid activates the enzyme acid sphingomyelinase (aSMase) leading to the generation of ceramides. A major target molecule of ceramide action is caspase 8, which, in turn, cleaves the pro-apoptotic factor bid into its active conformation. The next series of experiments investigated the role of microparticles in downstream activation of caspase 8. Stimulation of RAW 264.7 macrophages with Jurkat-derived microparticles showed a strong activation of caspase 8 as determined by fluorimetric analysis after 36 h (Fig. 5) . Basal rate was determined by measuring the caspase 8 activity of unstimulated cells.
To explore these mechanisms further, we investigated the effect of Ptins(3,5)BP on 10 5 RAW 264.7 macrophages when co-incubated with 3 × 10 6 Jurkat-derived microparticles. The addition of microparticles increased the basal enzymatic activity of caspase 8 by 33 ± 6% from 3568 ± 5 relative fluorescence units (RFU) to 4517 ± 621. Similar to the results of our previous experiments, Ptins (3, 5) RFU by using 5 µM and 3539 ± 196 RFU by using 10 µM PtdIns(3,5)BP (p < 0.05), respectively.
The effects of microparticles on MAP-Kinases
Microparticles have been suggested to be a preferred substrate for phospholipases A2, which cleave membrane phospholipids into arachidonic acid [14] . Several members of the MAP-Kinase pathway, in particular the extracellular signal regulated kinase (ERK-)1, play an important role in activating phospholipases A2. Thus, we tested the effects of microparticles on these downstream signalling events. When analysed by FACS using Cytobeads, 3 × 10 6 Jurkatderived microparticles strongly increased the amount of phosphorylated ERK1/2 in RAW 264.7 macrophages from 63.2 ± 30.4% to 286.6 ± 51.7% in a time-dependent manner, peaking 15 minutes after co-incubation (Fig. 6) . Similar results were observed for other members of the MAPKinase pathway (i.e. JNK1/2), although to a lesser extent. Subsequently, we added PD98059, a specific inhibitor of ERK1, to RAW macrophages exposed to microparticles. PD98059 resulted in an abrogation (27.7 ± 4.2%) of the apoptosis-promoting effects of Jurkat-derived microparticles in RAW 264.7 cells as assessed 6 h after incubation by FACS analysis.
To exclude the possibility that the observed reduction in the Annexin V-positive population after co-incubation with microparticles and PD098059 resulted from a reduction of the spontaneous rate of apoptosis, U937 cells were incubated with various concentrations of PD098059 alone. Analysis of Annexin V positive cells after 6 h showed no differences between untreated cells and MEK1/ERK1-inhibited cells. Furthermore, the treatment with Ptins(3,5)BP had no effects on cell viability at the concentrations used in the study, as measured by trypan blue exclusion (see experimental procedures). Together, these findings indicate a role of ceramide acting via MAP-Kinases in the induction of apoptosis by microparticles.
Discussion
Results of these studies provide new insight into the biological activities of microparticles and demonstrate a role of lipids in the apoptosis-inducing effects of these structures. Thus, we have shown that microparticles preparations derived from activated cell lines induce the apoptosis program in RAW 264.7 macrophages [10] . This induction occurred with microparticles derived both Jurkat and U937 cells, suggesting a common mechanism for the induction of apoptosis. Since microfilters strongly reduced the microparticleinduced apoptosis, cell-cell contact, most likely involving phagocytosis, may play an important role for the apoptosis response. This possibility is further supported by the observation that cells with a low phagocytic capacity did not undergo apoptosis under conditions in which macrophage cell lines demonstrated this response. Since cell death was inhibited completely by the addition of microparticle-free supernatant but not by using microfilters, however, it is possible that, during culture, microparticles release fragments with membraneous phospholipids which may pass the filter to interact with macrophages due to their smaller size.
Together with previous observations on the activity of microparticles, these findings suggest that microparticles induce apoptosis by a dysregulation of phospholipidarachidonate pathway rather than interaction with a specific surface receptor. Microparticles represent a population of vesicles of 200-700 nm size surrounded by a packed phospholipid bilayer originating from the cell membranes. These particles can interact with, and enter target, cells during phagocytosis. In this process, a rapid redistribution of arachidonate from releasable pools by phospholipases A2 may increase the levels of free unesterified arachidonic acid. This lipid mediator appears to be an important signal both for inhibiting cell proliferation and inducing apoptosis by regulating gene expression, controlling transcription factors, and generation of inflammatory mediators [40] [41] [42] .
Among its actions, arachidonic acid can activate acid sphingomyelinase to metabolize sphingomyelin into C2/C16-ceramides and, thereby, initiate the apoptotic cascade. Studies on a variety of systems indicate that maintenance of arachidonate levels is important for homeostasis and a necessary condition for cell growth and survival. It is of interest, in this regard, that cancer cells depleted of arachidonate display an increased resistance to apoptosis. Furthermore, the intracellular accumulation of arachidonic acid following treatment with nonsteroidal anti-inflammatory drugs may be beneficial in treatment of colorectal cancer by leading to the generation of ceramides and, ultimately, the induction of apoptosis [11, 14] .
Using phosphatidylinositol-3,5-biphosphate (Ptins(3, 5)BP), a specific inhibitor of the arachidonate-dependent enzyme acid sphingomyelinase, we identified sphingomyelin as a key mediator in microparticle-induced apoptosis. Thus, in our experiments, Ptins(3,5)BP reduced the occurrence of apoptosis in microparticle-treated macrophage cells in a dose-dependent manner without affecting the spontaneous rate of apoptosis in these cells. To clarify further the mechanisms of this response, we investigated the role of MAPKinases. These kinases could play a role in apoptosis if, during particle interaction with the target cell, membrane phospholipids from microparticles are cleaved by the enzyme phospholipase A2. In this context, the cytosolic isoform of phospholipase A 2 shows a strong preference for sn-2 bond arachidonic acid over other fatty acids and appears to mediate stimulus-coupled release of arachidonate during inflammatory processes [43] . Furthermore, serine phosphoacceptor sites, which are phosphorylated by MAP-Kinases, are essential for the stimulus-coupled activation of cytosolic phospholipase A 2 [44, 45] .
As shown in these experiments, microparticles strongly induced the phosphorylation of ERK1/2, a tyrosine kinase central to the operation of the MAP-Kinase pathway, in a time-dependent manner. In addition, the specific MAPKinase inhibitor PD098059 caused a marked reduction in the population of early apoptotic cells induced by treatment of macrophages with microparticles, further supporting the role of this pathway. Based on these results, we propose that microparticles induce apoptosis in phagocytes by disturbing the lipid content of cells, in particular, by increasing the concentration free arachidonic acid (Fig. 7) . Arachidonic acid in turn can stimulate the activity of acid sphingomyelinase to generate ceramides that trigger apoptosis. Since microparticles can activate this response, it appears likely that these structures provide phospholipids substrates that are preferentially cleaved by phospholipases to provide a source of arachidonate. This preference may result from the subcellular location of the particles during phagocytosis or other cellular changes occurring during this process.
As reported previously [10] , in clinical situations with high levels of circulating microparticles or excessive apoptosis such as malignancies, autoimmune syndromes and chemotherapy, microparticles might set off an amplification loop of apoptosis in phagocytosing cells thus suppressing the immune response by loss of macrophages. By describing an important intracellular pathway of this mechanism, our results might help to identify novel therapeutic strategies to overcome complications of these severe clinical entities.
In summary, these studies demonstrate that microparticles from immune cells can induce apoptosis in macrophage cell lines as well as primary macrophages. This process can be inhibited by interfering with the phospholipid-arachidonate remodelling, suggesting that the apoptotic cascade induced by interaction of microparticles with phagocytosing cells is mediated by the arachidonate-ceramide pathway. We have suggested previously that the ingestion of microparticles may represent a novel and specific mechanism for the induction of apoptosis in macrophages that could be operative in a number of clinical settings, including sepsis, systemic inflammation and malignancy. In these settings, the extent of microparticle release may increase, thereby causing subsequent immune system derangement [10] . Here, we propose a molecular mechanism underlying this phenomenon. Moreover, our results emphasize the importance of lipids in the cross-talk of immune cells that can operate with both intact cells as well as subcellular vesicles. Future studies will investigate the potency of these particles as a source of membrane lipids that can trigger cellular responses.
